-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Ionis Pharmaceuticals, Lowers Price Target to $70

Benzinga·11/10/2026 12:09:47
Listen to the news
HC Wainwright & Co. analyst Mitchell S. Kapoor maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Buy and lowers the price target from $100 to $70.